CEO Mark Capone talks about the importance we place on research collaborations and the role molecular diagnostics play in tailoring treatments for patients. “Research collaborations are part of the reason that we’ve been so successful in some of the pioneering discoveries that we have made at Myriad.”

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.